AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 12 filers reported holding AKARI THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3 | -40.0% | 16,437 | +56.7% | 0.00% | -100.0% |
Q4 2022 | $5 | -100.0% | 10,491 | -37.1% | 0.00% | 0.0% |
Q1 2022 | $20,000 | -50.0% | 16,676 | -8.0% | 0.00% | -80.0% |
Q2 2020 | $40,000 | -24.5% | 18,129 | -41.8% | 0.01% | +25.0% |
Q3 2019 | $53,000 | +140.9% | 31,124 | +185.8% | 0.00% | +300.0% |
Q2 2019 | $22,000 | -84.6% | 10,892 | -72.7% | 0.00% | -87.5% |
Q1 2019 | $143,000 | +146.6% | 39,864 | +33.8% | 0.01% | +166.7% |
Q2 2018 | $58,000 | – | 29,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 369,490 | $3,144,000 | 1.61% |
Vivo Capital, LLC | 527,842 | $4,492,000 | 1.40% |
VHCP Management, LLC | 158,352 | $1,348,000 | 1.33% |
Foresite Capital Management III, LLC | 197,072 | $1,677,000 | 0.78% |
Boxer Capital, LLC | 139,899 | $1,191,000 | 0.53% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,150,700 | $9,792,000 | 0.46% |
NEA Management Company, LLC | 452,167 | $3,848,000 | 0.17% |
RA Capital Management | 114,039 | $970,000 | 0.10% |
ACUTA CAPITAL PARTNERS, LLC | 23,169 | $197,000 | 0.07% |
QVT Financial LP | 263,921 | $1,833,000 | 0.07% |